Literature DB >> 3011301

Human tanapox in Zaire: clinical and epidemiological observations on cases confirmed by laboratory studies.

Z Jezek, I Arita, M Szczeniowski, K M Paluku, K Ruti, J H Nakano.   

Abstract

Human tanapox, a mild disease characterized by a short febrile illness associated with one or more skin lesions, is important because of its possible confusion with smallpox. The article describes clinical and epidemiological features of 264 laboratory-confirmed tanapox cases observed in a geographically limited area in northern Zaire over the period 1979-83.

Entities:  

Mesh:

Year:  1985        PMID: 3011301      PMCID: PMC2536461     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  Tanapox. A serological survey of the lower Tana River Valley.

Authors:  J S Axford; A W Downie
Journal:  J Hyg (Lond)       Date:  1979-10

2.  Serological evidence of infection with Tana and Yaba pox viruses among several species of monkey.

Authors:  A W Downie
Journal:  J Hyg (Lond)       Date:  1974-04

3.  Persistence of tanapox in Tana River valley.

Authors:  P E Manson-Bahr; A W Downie
Journal:  Br Med J       Date:  1973-04-21

4.  A contagious pox disease in monkeys.

Authors:  A S Hall; W P McNulty
Journal:  J Am Vet Med Assoc       Date:  1967-10-01       Impact factor: 1.936

5.  Comparison of Tanapox virus and Yaba-like viruses causing epidemic disease in monkeys.

Authors:  A W Downie; C España
Journal:  J Hyg (Lond)       Date:  1972-03

6.  Tanapox: a new disease caused by a pox virus.

Authors:  A W Downie; C H Taylor-Robinson; A E Caunt; G S Nelson; P E Manson-Bahr; T C Matthews
Journal:  Br Med J       Date:  1971-02-13
  6 in total
  12 in total

1.  Orthopox Viruses: Infections in Humans.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

2.  Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice.

Authors:  Tiantian Zhang; Yogesh R Suryawanshi; Dennis H Kordish; Helene M Woyczesczyk; David Jeng; Karim Essani
Journal:  Virus Genes       Date:  2016-10-13       Impact factor: 2.332

Review 3.  Human poxvirus infection after the eradication of smallpox.

Authors:  D Baxby
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

4.  Differential susceptibility of human cancer cell lines to wild-type tanapoxvirus infection.

Authors:  Hui Lin Lee; Karim Essani
Journal:  Open Virol J       Date:  2010-04-08

Review 5.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

6.  Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.

Authors:  Tiantian Zhang; Yogesh R Suryawanshi; Blair R Szymczyna; Karim Essani
Journal:  Med Oncol       Date:  2017-06-07       Impact factor: 3.738

7.  Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.

Authors:  Steven J Conrad; Mohamed El-Aswad; Esaw Kurban; David Jeng; Brian C Tripp; Charles Nutting; Robert Eversole; Charles Mackenzie; Karim Essani
Journal:  J Exp Clin Cancer Res       Date:  2015-02-19

8.  Estimating the geographic distribution of human Tanapox and potential reservoirs using ecological niche modeling.

Authors:  Benjamin P Monroe; Yoshinori J Nakazawa; Mary G Reynolds; Darin S Carroll
Journal:  Int J Health Geogr       Date:  2014-09-25       Impact factor: 3.918

9.  Serologic evidence for novel poxvirus in endangered red Colobus monkeys, Western Uganda.

Authors:  Tony L Goldberg; Colin A Chapman; Kenneth Cameron; Tania Saj; William B Karesh; Nathan D Wolfe; Scott W Wong; Melissa E Dubois; Mark K Slifka
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

10.  Engineered Promoter-Switched Viruses Reveal the Role of Poxvirus Maturation Protein A26 as a Negative Regulator of Viral Spread.

Authors:  David Ulaeto; Carlos Maluquer de Motes; Joe Holley; Rebecca P Sumner; Sian Lant; Paolo Ribeca
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.